Please use this identifier to cite or link to this item: http://repositorio.unitau.br/jspui/handle/20.500.11874/1873
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSaad, Wilson Abraopt_BR
dc.contributor.authorGuarda, Ismael Francisco Motta Siqueirapt_BR
dc.contributor.authorCamargo, Luiz Antonio de Arrudapt_BR
dc.contributor.authorSantos, Talmir Augusto Faria Brizola dospt_BR
dc.contributor.authorSimões, Sylviopt_BR
dc.contributor.authorSaad, William Abraopt_BR
dc.date.accessioned2019-09-12T16:26:07Z-
dc.date.available2019-09-12T16:26:07Z-
dc.date.issued2006-
dc.citation.volume6pt_BR
dc.citation.issue4pt_BR
dc.citation.spage597-
dc.citation.epage602-
dc.identifier.doi10.3923/jms.2006.597.602pt_BR
dc.identifier.issn16824474-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-33750375543&doi=10.3923%2fjms.2006.597.602&partnerID=40&md5=4509eed008e13755ce4f4a7fdfe7f560-
dc.identifier.urihttp://repositorio.unitau.br/jspui/handle/20.500.11874/1873-
dc.description.abstractThe median preoptic nucleus (MnPO) is one of most important site of the lamina terminalis implicated in the regulation of hydro electrolytic and cardiovascular balance. The purpose of this study was to determine the effect of L-Type calcium channel antagonist, nifedipine, on the increase of median arterial blood pressure (MAP) induce by angiotensin II (ANG II) injected into the MnPO. The influence of nitric oxide (NO) on nifedipine antipressor action has also been studied by utilizing NW-nitro-L-arginine methyl ester (L-NAME) (40 μg 0.2 μL-1) a NO synthase inhibitor (NOSI), 7-nitroindazole (7-NIT) (40 μg 0.2 μL-1), a specific neuronal NO synthase inhibitor (nNOSI) and sodium nitroprusside (SNP) (20 μg 0.2 μL-1) a NO donor agent. We have also investigated the central role of losartan and PD123349 (20 nmol 0.2 μL-1), AT1 and AT2, respectively (selective non peptide ANG II receptor antagonists), in the pressor effect of ANG II (25 pmol 0.2 μL-1) injected into the MnPO. Male Wistar rats weighting 200-250 g, with cannulae implanted into the MnPO were utilized. Losartan injected into the MnPO, prior to ANG II, blocked the pressor effect of ANGII. PD 123319 only decreased the pressor effect of ANG II. Rats pre-treated with either 50 μg 0.2 μL-1 or 100 μg 0.2 μL-1 of nifedipine, followed by 25 pmol 0.2 μL-1 of ANG II, decreased ANG II-pressor effect. L-NAME potentiated the pressor effect of ANG II. 7-NIT injected prior to ANG II into the MnPO also potentiated the pressor effect of ANGII but with less intensity than that of L-NAME. SNP injected prior to ANG II blocked the pressor effect of ANG II. The potentiation action of L-NAME and 7-NIT on ANG II-pressor effect was blocked by prior injection of nifedipine. The results described in this study provide evidence that calcium channels play important roles in central ANG II-induced pressor effect. The structures containing NO in the brain, such as MnPO, include both endothelial and neuronal cells, which might be responsible for the influence of nifedipine on the pressor effect of ANG II. These data have shown the functional relationship between L-Type calcium channel and a free radical gas NO in the MnPO, on the control of ANG II-induced pressor effect acting in AT1 and AT2 receptors.en
dc.description.abstractO núcleo pré-óptico mediano (MnPO) é um dos locais mais importantes da lâmina terminal, implicado na regulação do equilíbrio hidroeletrolítico e cardiovascular. O objetivo deste estudo foi determinar o efeito do antagonista dos canais de cálcio do tipo L, a nifedipina, no aumento da pressão arterial média (PAM) induzida pela angiotensina II (ANG II) injetada no MnPO. A influência do óxido nítrico (NO) na ação antipressora da nifedipina também foi estudada utilizando o éster metílico de N <SUP> W </SUP> -nitro-L-arginina (L-NAME) (40 µg 0,2 µL) Um inibidor da NO sintase (NOSI), 7-nitroindazol (7-NIT) (40 μg 0,2 μL L), um inibidor neuronal específico da NO sintase (nNOSI) e nitroprussiato de sódio ( SNP) (20 × 0, 2 × L <SUP> -1 </SUP>) um agente doador de NO. Também investigamos o papel central do losartan e PD123349 (20 nmol 0,2 μL <SUP> -1 </SUP>), AT <SUB> 1 </SUB> e AT <SUB> 2 </SUB>, respectivamente (seletivos antagonistas dos receptores ANG II não peptídicos), no efeito pressor de ANG II (25 pmol 0,2 µL L -1) injetado no MnPO. Utilizaram-se ratos Wistar machos, com peso entre 200 e 250 g, com cânulas implantadas no MnPO. Losartan injetado no MnPO, antes do ANG II, bloqueou o efeito pressor do ANGII. PD 123319 apenas diminuiu o efeito pressor de ANG II. Ratos pré-tratados com 50 µg 0,2 µL <SUP> -1 </SUP> ou 100 µg 0,2 µL <SUP> -1 </SUP> de nifedipina, seguidos por 25 pmol 0,2 µL <SUP> -1 </ SUP > de ANG II, diminuição do efeito pressórico de ANG II. L-NAME potencializou o efeito pressor de ANG II. O 7-NIT injetado antes do ANG II no MnPO também potencializou o efeito pressor do ANGII, mas com menos intensidade do que o do L-NAME. O SNP injetado antes do ANG II bloqueou o efeito pressor do ANG II. A ação de potenciação de L-NAME e 7-NIT no efeito pressor de ANG II foi bloqueada por injeção prévia de nifedipina. Os resultados descritos neste estudo fornecem evidências de que os canais de cálcio desempenham papéis importantes no efeito pressórico induzido por ANG II central. As estruturas que contêm NO no cérebro, como MnPO, incluem células endoteliais e neuronais, que podem ser responsáveis pela influência da nifedipina no efeito pressor da ANG II. Esses dados demonstraram a relação funcional entre o canal de cálcio do tipo L e um gás de radical livre NO no MnPO, no controle do efeito pressor induzido por ANG II que atua em AT <SUB> 1 </SUB>pt_BR
dc.description.provenanceMade available in DSpace on 2019-09-12T16:26:07Z (GMT). No. of bitstreams: 0 Previous issue date: 2006en
dc.languageInglêspt_BR
dc.relation.ispartofJournal of Medical Sciences-
dc.rightsAcesso Abertopt_BR
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceScopuspt_BR
dc.subject.otherAngiotensin IIen
dc.subject.otherBlood pressureen
dc.subject.otherCalcium channelen
dc.subject.otherMnPOen
dc.subject.otherNitric oxideen
dc.subject.otherRatsen
dc.subject.other1 (4 dimethylamino 3 methylbenzyl) 5 diphenylacetyl 4,5,6,7 tetrahydro 1h imidazo[4,5 c]pyridine 6 carboxylic aciden
dc.subject.other7 nitroindazoleen
dc.subject.otherangiotensinen
dc.subject.otherangiotensin 1 receptoren
dc.subject.otherangiotensin 2 receptoren
dc.subject.otherangiotensin 2 receptor antagonisten
dc.subject.otherangiotensin Ien
dc.subject.othercalcium channel L typeen
dc.subject.otherlosartanen
dc.subject.othern(g) nitroarginine methyl esteren
dc.subject.othernifedipineen
dc.subject.othernitric oxideen
dc.subject.othernitroprusside sodiumen
dc.subject.otheranimal experimenten
dc.subject.otherarticleen
dc.subject.otherblood pressure measurementen
dc.subject.othercardiovascular functionen
dc.subject.othercontrolled studyen
dc.subject.otherdose responseen
dc.subject.otherdrug effecten
dc.subject.otherendothelium cellen
dc.subject.otherhomeostasisen
dc.subject.othermaleen
dc.subject.othermean arterial pressureen
dc.subject.othernerve cellen
dc.subject.othernitrergic nerveen
dc.subject.othernonhumanen
dc.subject.otherpreoptic nucleusen
dc.subject.otherpressor responseen
dc.subject.otherraten
dc.titleNitrergic pathways and L-type calcium channel of MnPO influencing cardiovascular homeostasisen
dc.title.alternativeVias Nitrérgicas e Canal de Cálcio do Tipo L da MnPO que Influenciam a Homeostase Cardiovascularpt_BR
dc.typeArtigo de Periódicopt_BR
dc.description.affiliationSaad, W.A., Basic Institute of Biosciences, UNITAU, Taubaté, SP, Brazil, Department of Exact and Natural Science, UNIARA, Araraquara, SP, Brazil, Department of Physiology and Pathology, School of Dentistry, Paulista State University, Rua Humaitá 1680, 14801-903-Araraquara, SP, Brazil, Department of Anesthesiology Clinic Hospital State of Sao Paulo, Sao Paulo, Brazil, Department of Physiology, Federal University of São Carlos, São Carlos, SP, Brazil, Department of Gastroenterology, Clinic Hospital of University of São Paulo, São Paulo, Brazil-
dc.description.affiliationGuarda, I.F.M.S., Department of Anesthesiology Clinic Hospital State of Sao Paulo, Sao Paulo, Brazil-
dc.description.affiliationCamargo, L.A. de A., Department of Physiology and Pathology, School of Dentistry, Paulista State University, Rua Humaitá 1680, 14801-903-Araraquara, SP, Brazil-
dc.description.affiliationdos Santos, T.A.F.B., Basic Institute of Biosciences, UNITAU, Taubaté, SP, Brazil-
dc.description.affiliationSimões, S., Basic Institute of Biosciences, UNITAU, Taubaté, SP, Brazil-
dc.description.affiliationSaad, W.A., Basic Institute of Biosciences, UNITAU, Taubaté, SP, Brazil, Department of Exact and Natural Science, UNIARA, Araraquara, SP, Brazil, Department of Physiology and Pathology, School of Dentistry, Paulista State University, Rua Humaitá 1680, 14801-903-Araraquara, SP, Brazil, Department of Anesthesiology Clinic Hospital State of Sao Paulo, Sao Paulo, Brazil, Department of Physiology, Federal University of São Carlos, São Carlos, SP, Brazil, Department of Gastroenterology, Clinic Hospital of University of São Paulo, São Paulo, Brazil-
dc.identifier.scopus2-s2.0-33750375543-
dc.contributor.scopus7102555761pt_BR
dc.contributor.scopus6508355383pt_BR
dc.contributor.scopus35963541600pt_BR
dc.contributor.scopus35577775000pt_BR
dc.contributor.scopus7007015021pt_BR
dc.contributor.scopus7102555761pt_BR
Appears in Collections:Artigos de Periódicos

Files in This Item:
File SizeFormat 
2-s2.0-33750375543.pdf634.08 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons